Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company specializing in treatments for central nervous system (CNS) disorders, announced that its CEO, Sharon Mates, Ph.D., will present at the Jefferies Global Healthcare Conference. This event is scheduled for June 5, 2024, at 11:00 a.m. ET in New York, NY. A live and archived webcast will be available on the company's website under the Investor Relations section. Viewers are advised to log in 5-10 minutes early to register and install necessary software.

Positive

• CEO Sharon Mates, Ph.D., presenting at a high-profile event like the Jefferies Global Healthcare Conference boosts ITCI’s visibility.
• The presentation underscores ITCI's commitment to investor relations and transparency.
• Availability of a live and archived webcast expands the reach to a broader audience, including potential investors.

Negative

• No new financial or clinical data disclosed in the announcement, offering immediate insights for investors.
• The requirement for viewers to log in early and install software may deter some potential audience members.

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 a.m. ET in New York, NY.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

FAQ

When is Intra-Cellular Therapies presenting at the Jefferies Global Healthcare Conference?

Intra-Cellular Therapies is presenting on June 5, 2024, at 11:00 a.m. ET.

Who is presenting on behalf of Intra-Cellular Therapies at the Jefferies Global Healthcare Conference?

Sharon Mates, Ph.D., CEO and Chairman of Intra-Cellular Therapies, will be presenting.

Where can I access the webcast of Intra-Cellular Therapies’ presentation?

The webcast can be accessed under the 'Events & Presentations' section on Intra-Cellular Therapies' website.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing and commercializing therapeutics for central nervous system (CNS) disorders.